eMedicine Specialties > Gastroenterology > Esophagus
Barrett Esophagus and Barrett Ulcer: Follow-up
Updated: Jun 1, 2009
Follow-up
Prognosis
- Most patients with Barrett esophagus will not develop esophageal cancer and will die of other causes, as in the general population. The risk of progression to adenocarcinoma of the esophagus is estimated at approximately 0.5% per year in patients without dysplasia on initial surveillance biopsies. Why only some people with GERD develop Barrett esophagus also is not clear.
Miscellaneous
Medicolegal Pitfalls
- The association of chronic GERD with Barrett esophagus and its inherent risk of progression to adenocarcinoma of the esophagus is established. Consequently, any patient aged 50 years or older, male or female, with a history of chronic GERD should have at least a 1-time upper endoscopy to screen for Barrett esophagus. Failure to recommend endoscopy or at least to discuss the cancer risk in this situation could lead to litigation, should such a diagnosis be missed.
More on Barrett Esophagus and Barrett Ulcer |
| Overview: Barrett Esophagus and Barrett Ulcer |
| Differential Diagnoses & Workup: Barrett Esophagus and Barrett Ulcer |
| Treatment & Medication: Barrett Esophagus and Barrett Ulcer |
Follow-up: Barrett Esophagus and Barrett Ulcer |
| Multimedia: Barrett Esophagus and Barrett Ulcer |
| References |
| « Previous Page | Next Page » |
References
Barrett NR. Chronic peptic ulcer of the oesophagus and 'oesophagitis'. Br J Surg. Oct 1950;38(150):175-82. [Medline].
Allison PR, Johnstone AS. The oesophagus lined with gastric mucous membrane. Thorax. Jun 1953;8(2):87-101. [Medline].
Barrett NR. The lower esophagus lined by columnar epithelium. Surgery. Jun 1957;41(6):881-94. [Medline].
Paull A, Trier JS, Dalton MD, Camp RC, Loeb P, Goyal RK. The histologic spectrum of Barrett's esophagus. N Engl J Med. Aug 26 1976;295(9):476-80. [Medline].
Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology. Dec 2005;129(6):1825-31. [Medline].
Cameron AJ. Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol Clin North Am. Sep 1997;26(3):487-94. [Medline].
Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. Mar 13 1991;265(10):1287-9. [Medline].
Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology. Feb 1993;104(2):510-3. [Medline].
Haag S, Nandurkar S, Talley NJ. Regression of Barrett's esophagus: the role of acid suppression, surgery, and ablative methods. Gastrointest Endosc. Aug 1999;50(2):229-40. [Medline].
Prasad GA, Wang KK, Buttar NS, Wongkeesong LM, Krishnadath KK, Nichols FC 3rd, et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. Gastroenterology. Apr 2007;132(4):1226-33. [Medline].
Shaheen NJ, Sharma P, Overholt BF, et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med. May 28 2009;360(22):2277-88. [Medline]. [Full Text].
Overholt BF, Panjehpour M, Haydek JM. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest Endosc. Jan 1999;49(1):1-7. [Medline].
Sampliner RE, Fennerty B, Garewal HS. Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results. Gastrointest Endosc. Nov 1996;44(5):532-5. [Medline].
Bremner RM, Mason RJ, Bremner CG, DeMeester TR, Chandrasoma P, Peters JH, et al. Ultrasonic epithelial ablation of the lower esophagus without stricture formation. A new technique for Barrett's ablation. Surg Endosc. Apr 1998;12(4):342-6; discussion 346-7. [Medline].
Dodds WJ, Dent J, Hogan WJ, Helm JF, Hauser R, Patel GK, et al. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med. Dec 16 1982;307(25):1547-52. [Medline].
Johnston CM, Schoenfeld LP, Mysore JV, Dubois A. Endoscopic spray cryotherapy: a new technique for mucosal ablation in the esophagus. Gastrointest Endosc. Jul 1999;50(1):86-92. [Medline].
Kahrilas PJ, Dodds WJ, Hogan WJ, Kern M, Arndorfer RC, Reece A. Esophageal peristaltic dysfunction in peptic esophagitis. Gastroenterology. Oct 1986;91(4):897-904. [Medline].
Pereira-Lima JC, Busnello JV, Saul C, Toneloto EB, Lopes CV, Rynkowski CB, et al. High power setting argon plasma coagulation for the eradication of Barrett's esophagus. Am J Gastroenterol. Jul 2000;95(7):1661-8. [Medline].
Sampliner RE. Ablative therapies for the columnar-lined esophagus. Gastroenterol Clin North Am. Sep 1997;26(3):685-94. [Medline].
Sampliner RE. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. Jul 1998;93(7):1028-32. [Medline].
Spechler SJ, Goyal RK. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. Gastroenterology. Feb 1996;110(2):614-21. [Medline].
Ter RB, Castell DO. Gastroesophageal reflux disease in patients with columnar-lined esophagus. Gastroenterol Clin North Am. Sep 1997;26(3):549-63. [Medline].
Wong RKH. Barrett's esophagus. Pract Gastroenterol. 2000;24:15-35.
Further Reading
Keywords
Barrett esophagus, Barrett's esophagus, BE, Barrett's ulcer, specialized intestinal metaplasia, SIM, goblet cells, columnar lined esophagus, columnar-lined esophagus, Barrett's metaplasia, Barrett metaplasia, esophageal carcinoma, chronic gastroesophageal reflux, chronic GER, gastroesophageal reflux disease, GERD
Follow-up: Barrett Esophagus and Barrett Ulcer